201 related articles for article (PubMed ID: 31209014)
1. Efflux-Mediated Resistance to New Oxazolidinones and Pleuromutilin Derivatives in Escherichia coli with Class Specificities in the Resistance-Nodulation-Cell Division-Type Drug Transport Pathways.
Schuster S; Vavra M; Kern WV
Antimicrob Agents Chemother; 2019 Sep; 63(9):. PubMed ID: 31209014
[TBL] [Abstract][Full Text] [Related]
2. Altered spectrum of multidrug resistance associated with a single point mutation in the Escherichia coli RND-type MDR efflux pump YhiV (MdtF).
Bohnert JA; Schuster S; Fähnrich E; Trittler R; Kern WV
J Antimicrob Chemother; 2007 Jun; 59(6):1216-22. PubMed ID: 17062614
[TBL] [Abstract][Full Text] [Related]
3. Evidence of a Substrate-Discriminating Entrance Channel in the Lower Porter Domain of the Multidrug Resistance Efflux Pump AcrB.
Schuster S; Vavra M; Kern WV
Antimicrob Agents Chemother; 2016 Jul; 60(7):4315-23. PubMed ID: 27161641
[TBL] [Abstract][Full Text] [Related]
4. Random mutagenesis of the multidrug transporter AcrB from Escherichia coli for identification of putative target residues of efflux pump inhibitors.
Schuster S; Kohler S; Buck A; Dambacher C; König A; Bohnert JA; Kern WV
Antimicrob Agents Chemother; 2014 Nov; 58(11):6870-8. PubMed ID: 25182653
[TBL] [Abstract][Full Text] [Related]
5. Multiple entry pathways within the efflux transporter AcrB contribute to multidrug recognition.
Zwama M; Yamasaki S; Nakashima R; Sakurai K; Nishino K; Yamaguchi A
Nat Commun; 2018 Jan; 9(1):124. PubMed ID: 29317622
[TBL] [Abstract][Full Text] [Related]
6. Chlorpromazine and Amitriptyline Are Substrates and Inhibitors of the AcrB Multidrug Efflux Pump.
Grimsey EM; Fais C; Marshall RL; Ricci V; Ciusa ML; Stone JW; Ivens A; Malloci G; Ruggerone P; Vargiu AV; Piddock LJV
mBio; 2020 Jun; 11(3):. PubMed ID: 32487753
[TBL] [Abstract][Full Text] [Related]
7. AcrB drug-binding pocket substitution confers clinically relevant resistance and altered substrate specificity.
Blair JM; Bavro VN; Ricci V; Modi N; Cacciotto P; Kleinekathӧfer U; Ruggerone P; Vargiu AV; Baylay AJ; Smith HE; Brandon Y; Galloway D; Piddock LJ
Proc Natl Acad Sci U S A; 2015 Mar; 112(11):3511-6. PubMed ID: 25737552
[TBL] [Abstract][Full Text] [Related]
8. Site-directed mutagenesis reveals putative substrate binding residues in the Escherichia coli RND efflux pump AcrB.
Bohnert JA; Schuster S; Seeger MA; Fähnrich E; Pos KM; Kern WV
J Bacteriol; 2008 Dec; 190(24):8225-9. PubMed ID: 18849422
[TBL] [Abstract][Full Text] [Related]
9. New Topoisomerase Inhibitors: Evaluating the Potency of Gepotidacin and Zoliflodacin in Fluoroquinolone-Resistant Escherichia coli upon
Schuster S; Vavra M; Köser R; Rossen JWA; Kern WV
Antimicrob Agents Chemother; 2021 Jan; 65(2):. PubMed ID: 33199388
[TBL] [Abstract][Full Text] [Related]
10. Pyridylpiperazine-based allosteric inhibitors of RND-type multidrug efflux pumps.
Plé C; Tam HK; Vieira Da Cruz A; Compagne N; Jiménez-Castellanos JC; Müller RT; Pradel E; Foong WE; Malloci G; Ballée A; Kirchner MA; Moshfegh P; Herledan A; Herrmann A; Deprez B; Willand N; Vargiu AV; Pos KM; Flipo M; Hartkoorn RC
Nat Commun; 2022 Jan; 13(1):115. PubMed ID: 35013254
[TBL] [Abstract][Full Text] [Related]
11. Characterization of all RND-type multidrug efflux transporters in Vibrio parahaemolyticus.
Matsuo T; Nakamura K; Kodama T; Mikami T; Hiyoshi H; Tsuchiya T; Ogawa W; Kuroda T
Microbiologyopen; 2013 Oct; 2(5):725-42. PubMed ID: 23894076
[TBL] [Abstract][Full Text] [Related]
12. Perturbed structural dynamics underlie inhibition and altered efflux of the multidrug resistance pump AcrB.
Reading E; Ahdash Z; Fais C; Ricci V; Wang-Kan X; Grimsey E; Stone J; Malloci G; Lau AM; Findlay H; Konijnenberg A; Booth PJ; Ruggerone P; Vargiu AV; Piddock LJV; Politis A
Nat Commun; 2020 Nov; 11(1):5565. PubMed ID: 33149158
[TBL] [Abstract][Full Text] [Related]
13. Reversal of the Drug Binding Pocket Defects of the AcrB Multidrug Efflux Pump Protein of Escherichia coli.
Soparkar K; Kinana AD; Weeks JW; Morrison KD; Nikaido H; Misra R
J Bacteriol; 2015 Oct; 197(20):3255-64. PubMed ID: 26240069
[TBL] [Abstract][Full Text] [Related]
14. Characterization of substituted piperazines able to reverse MDR in Escherichia coli strains overexpressing resistance-nodulation-cell division (RND) efflux pumps.
Casalone E; Vignolini T; Braconi L; Gardini L; Capitanio M; Pavone FS; Giovannelli L; Dei S; Teodori E
J Antimicrob Chemother; 2022 Feb; 77(2):413-424. PubMed ID: 34747445
[TBL] [Abstract][Full Text] [Related]
15. Molecular basis for inhibition of AcrB multidrug efflux pump by novel and powerful pyranopyridine derivatives.
Sjuts H; Vargiu AV; Kwasny SM; Nguyen ST; Kim HS; Ding X; Ornik AR; Ruggerone P; Bowlin TL; Nikaido H; Pos KM; Opperman TJ
Proc Natl Acad Sci U S A; 2016 Mar; 113(13):3509-14. PubMed ID: 26976576
[TBL] [Abstract][Full Text] [Related]
16. 1-benzyl-1,4-diazepane reduces the efflux of resistance-nodulation-cell division pumps in
Casalone E; Vignolini T; Braconi L; Gardini L; Capitanio M; Pavone FS; Dei S; Teodori E
Future Microbiol; 2020 Jul; 15():987-999. PubMed ID: 32840130
[No Abstract] [Full Text] [Related]
17. Substrate-dependent dynamics of the multidrug efflux transporter AcrB of Escherichia coli.
Yamamoto K; Tamai R; Yamazaki M; Inaba T; Sowa Y; Kawagishi I
Sci Rep; 2016 Feb; 6():21909. PubMed ID: 26916090
[TBL] [Abstract][Full Text] [Related]
18. AcrB, AcrD, and MdtABC multidrug efflux systems are involved in enterobactin export in Escherichia coli.
Horiyama T; Nishino K
PLoS One; 2014; 9(9):e108642. PubMed ID: 25259870
[TBL] [Abstract][Full Text] [Related]
19. A role for the periplasmic adaptor protein AcrA in vetting substrate access to the RND efflux transporter AcrB.
Alav I; Bavro VN; Blair JMA
Sci Rep; 2022 Mar; 12(1):4752. PubMed ID: 35306531
[TBL] [Abstract][Full Text] [Related]
20. Switch-loop flexibility affects transport of large drugs by the promiscuous AcrB multidrug efflux transporter.
Cha HJ; Müller RT; Pos KM
Antimicrob Agents Chemother; 2014 Aug; 58(8):4767-72. PubMed ID: 24914123
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
